Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs Wells Fargo & Co (WFC) Price & Performance

Cytokinetics IncTrade
Wells Fargo & CoTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Wells Fargo & Co — how do they compare? Cytokinetics Inc trades at $77.39 (market cap $10.63B), while Wells Fargo & Co trades at $87.3 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 24.9× Cytokinetics Inc's market cap, and Wells Fargo & Co pays a 2.29% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.

CYTKWFC
Market Cap
$10.63B$264.66B
Sector
TechnologyFinancials
52-Week High
$87.26$96.40
52-Week Low
$34.31$73.42
Enterprise Value
$10.74B
Dividend Yield
2.29%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK

About Wells Fargo & Co

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

Read more on WFC